Abstract
With advancement in the field of interventional cardiology, drug eluting stents (DES) with biodegradable polymer (BD) were developed in comparison to durable polymers (DP) to improve clinical outcomes in coronary artery disease. However, Results reported by multiple randomized controlled trials (RCTs) remain controversial.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of the Society for Cardiovascular Angiography & Interventions
Paper Title
Journal
Date
